Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.

Margarita García; Xavier García del Muro; Alejandro Tres; Carmen Crespo; Manuel Valladares; Juan José López; Julio Rifà; Xavier Pérez; Elena Filipovich; Josep Ramón Germà-Lluch

doi:10.1097/01.cmr.0000215042.53683.40

Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.

Identifier:nobleid.org/w1/20260515/3CB52FD1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3CB52FD1.svg?ark=w1%2F20260515%2F3CB52FD1)](https://nobleid.org/work/w1/20260515/3CB52FD1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Margarita García

Xavier García del Muro

Josep Ramón Germà-Lluch

Claim authorship of this work

Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.

Identifier:nobleid.org/w1/20260515/3CB52FD1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3CB52FD1.svg?ark=w1%2F20260515%2F3CB52FD1)](https://nobleid.org/work/w1/20260515/3CB52FD1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Margarita García

Xavier García del Muro

Josep Ramón Germà-Lluch

Claim authorship of this work